Poseida Therapeutics raised $142M Series C venture round, led by Novartis Pharma.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Novartis PharmaLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$312.5M
Top Valuation
-
Poseida Therapeutics raised $142M in a Series C round.
The round was announced on 04/22/19.
The round was led by Novartis Pharma.